quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 23, 2025

The Zacks Analyst Blog Highlights Ericsson, Nokia and CommScope

View original at finance.yahoo.com
The Zacks Analyst Blog Highlights Ericsson, Nokia and CommScope For Immediate Release Chicago, IL – December 23, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Ericsson delivered an earnings surprise of 13.51%, on average, in the trailing four quarters

    80% confidence

  • CommScope has a long-term earnings growth expectation of 13.48%

    80% confidence

  • 5G subscriptions in Southeast Asia and Oceania are projected to reach around 680 million in 2031

    80% confidence

  • CommScope delivered an earnings surprise of 143.98%, on average, in the trailing four quarters

    80% confidence

  • Ericsson has a long-term earnings growth expectation of 8.44%

    80% confidence

  • Mobile data traffic is expected to witness a 16% CAGR from 2024 to 2031

    80% confidence

  • The 5G services market is expected to witness a 62.2% CAGR between 2025 and 2030

    80% confidence

  • Shares of mobile data carried over 5G are expected to grow from 34% in 2024 to 83% in 2031

    80% confidence

  • The 5G infrastructure market is expected to witness a 13.1% compound annual growth rate between 2026 and 2033

    80% confidence

  • 5G technology is essential for national security

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
The Zacks Analyst Blog Highlights Ericsson, Nokia and CommScope — Source | Via News | pt.VIA.NEWS